Cargando…
Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin.
Intrinsic low-level resistance to anti-cancer drugs is a major problem in the treatment of gastrointestinal malignancies. To address the problem presented by intrinsically resistant tumours, we have isolated two monoclonal lines from LoVo human colon adenocarcinoma cells: LoVo/C7, which is intrinsic...
Autores principales: | Dolfini, E., Dasdia, T., Arancia, G., Molinari, A., Calcabrini, A., Scheper, R. J., Flens, M. J., Gariboldi, M. B., Monti, E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223778/ https://www.ncbi.nlm.nih.gov/pubmed/9218735 |
Ejemplares similares
-
Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin.
por: Conforti, G., et al.
Publicado: (1995) -
Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin
por: Ravizza, Raffaella, et al.
Publicado: (2004) -
Inhibition of protein kinase C-alpha isoform enhances the P-glycoprotein expression and the survival of LoVo human colon adenocarcinoma cells to doxorubicin exposure.
por: La Porta, C. A., et al.
Publicado: (1998) -
Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines.
por: Izquierdo, M. A., et al.
Publicado: (1996) -
Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin.
por: Grandi, M., et al.
Publicado: (1986)